Levonorgestrel-releasing intrauterine systems for long-acting contraception: current perspectives, safety, and patient counseling

References

• SedghGSinghSHussainRIntended and unintended pregnancies worldwide in 2012 and recent trendsStud Fam Plann201445330131425207494
   PubMed Web of Science ®Google Scholar
• World Health OrganizationWorld contraceptive use 2015 Available from: http://www.un.org/en/development/desa/population/publications/dataset/contraception/wcu2015.shtmlAccessed June 30, 2016
   Google Scholar
• HauckBCostescuDBarriers and misperceptions limiting widespread use of intrauterine contraception among Canadian womenJ Obstet Gynaecol Can201537760661626366817
   PubMed Web of Science ®Google Scholar
• BlackAYGuilbertEHassanFThe cost of unintended pregnancy in Canada: estimating direct cost, role of imperfect adherence, and the potential impact of increased use of long acting reversible contraceptivesJ Obstet Gynaecol Can201537121086109726637081
   PubMedGoogle Scholar
• FinerLBHenshawSKDisparities in rates of unintended pregnancy in the United States, 1994 and 2001Perspect Sex Reprod Health2006382909616772190
   PubMed Web of Science ®Google Scholar
• BlackAWangQWu WenSLalondeABGuilbertEFisherWContraceptive use among Canadian women of reproductive age: results of a national surveyJ Obstet Gynaecol Can200931762764019761636
   PubMedGoogle Scholar
• PazolKWhitemanMKFolgerSGKourtisAPMarchbanksPAJamiesonDJSporadic contraceptive use and nonuse: age-specific prevalence and associated factorsAm J Obstet Gynecol20152123324.e1324.e825305406
   PubMed Web of Science ®Google Scholar
• TrussellJContraceptive failure in the United StatesContraception201183539740421477680
   PubMed Web of Science ®Google Scholar
• FinerLBPhilbinJMTrends in ages at key reproductive transitions in the United States, 1951–2010Womens Health Issues2014243e271e27924721149
   PubMed Web of Science ®Google Scholar
• Statistics CanadaFertility: fewer children, older moms Available from: http://www.statcan.gc.ca/pub/11-630-x/11-630-x2014002-eng.htmAccessed June 30, 2016
   Google Scholar
• Statistics CanadaMarital status: overview, 2011 Catalogue No. 91-201-X2013
   Google Scholar
• BlackAGuilbertDCostescuDCanadian contraception consensus (Part 2)J Obstet Gynaecol Can201537111033103926629725
   PubMedGoogle Scholar
• SperoffLDarneyPIntrauterine contraceptionA Clinical Guide for ContraceptionPhiladelphia, PALippincott Williams & Wilkins2011
   Google Scholar
• NilssonCGLähteenmäkiPLuukkainenTPatterns of ovulation and bleeding with a low levonorgestrel-releasing intrauterine deviceContraception19802121551646768490
   PubMed Web of Science ®Google Scholar
• WadsworthPFHeywoodRAllenDGSortwellRJWaltonRMTreatment of rhesus monkeys (Macaca mulatta) with intrauterine devices loaded with levonorgestrelContraception1979202177184114355
   PubMed Web of Science ®Google Scholar
• NilssonCGLuukkainenTDiazJAllonenHIntrauterine contraception with levonorgestrel: a comparative randomised clinical performance studyLancet1981182205775806110819
   PubMed Web of Science ®Google Scholar
• LuukkainenTAllonenHHaukkamaaMLähteenmäkiPNilssonCGToivonenJFive years’ experience with levonorgestrel-releasing IUDsContraception19863321391483084167
   PubMed Web of Science ®Google Scholar
• Bayer Healthcare CanadaMirena product monograph2014 Available from: http://omr.bayer.ca/omr/online/mirena-pm-en.pdfAccessed June 30, 2016
   Google Scholar
• Bayer Healthcare CanadaJaydess product monograph2014 Available from: http://omr.bayer.ca/omr/online/jaydess-pm-en.pdfAccessed June 30, 2016
   Google Scholar
• Allergan Specialty PharmaceuticalsLiletta prescribing information Available from: www.allergan.com/assets/pdf/liletta_piAccessed June 30, 2016
   Google Scholar
• Bayer Healthcare Pharmaceuticals Press release Available from: http://www.prnewswire.com/news-releases/bayer-submits-new-drug-application-for-lcs-16-for-pregnancy-prevention-for-up-to-five-years-300182419.htmlAccessed June 30, 2016
   Google Scholar
• NelsonAApterDHauckBTwo low-dose levonorgestrel intrauterine contraceptive systems: a randomized controlled trialObstet Gynecol201312261205121324240244
   PubMed Web of Science ®Google Scholar
• Gemzell-DanielssonKSchellschmidtIApterDA randomized, phase II study describing the efficacy, bleeding profile, and safety of two low-dose levonorgestrel-releasing intrauterine contraceptive systems and MirenaFertil Steril201297361662222222193
   PubMed Web of Science ®Google Scholar
• BlackAGuilbertECostescuDCanadian contraception consensus – chapter 7 – intrauterine contraceptionJ Obstet Gynaecol Can201638218222227032746
   PubMed Web of Science ®Google Scholar
• PeipertJFZhaoQAllsworthJEContinuation and satisfaction of reversible contraceptionObstet Gynecol201111751105111321508749
   PubMed Web of Science ®Google Scholar
• SivinISternJDiazSRates and outcomes of planned pregnancy after use of Norplant capsules, Norplant II rods, or levonorgestrel-releasing or copper TCu 380Ag intrauterine contraceptive devicesAm J Obstet Gynecol19921664120812131566771
   PubMed Web of Science ®Google Scholar
• StoddardAMXuHMaddenTAllsworthJEPeipertJFFertility after intrauterine device removal: a pilot studyEur J Contracept Reprod Health Care201520322323025751567
   PubMed Web of Science ®Google Scholar
• UK Medicines and Healthcare Products Regulatory Agency/eMCMirena – summary of product characteristics (SPC) Available from: www.medicines.org.uk/emc/medicine/1829/spc/mirenaAccessed June 30, 2016
   Google Scholar
• RowePFarleyTPeregoudovASafety and efficacy in parous women of a 52-mg levonorgestrel-medicated intrauterine device: a 7-year randomized comparative study with the TCu380AContraception201693649850626916172
   PubMed Web of Science ®Google Scholar
• World Health OrganizationMedical eligibility criteria for contraceptive use5th edition2015 Available from: www.who.int/reproductivehealth/publications/family_planning/MEC-5/en/Accessed June 30, 2016
   Google Scholar
• CreininMDJansenRStarrRMGobburuJGopalakrishnanMOlariuALevonorgestrel release rates over 5 years with the Liletta 52 mg intrauterine systemContraception Epub2016425
   Web of Science ®Google Scholar
• CostescuDGuilbertEBlackASOGC clinical practice guideline: medical abortionJ Obstet Gynaecol Can201638436638927208607
   PubMed Web of Science ®Google Scholar
• HeinemannKReedSMoehnerSMinhTDComparative contraceptive effectiveness of levonorgestrel-releasing and copper intrauterine devices: the European Active Surveillance Study for Intrauterine DevicesContraception201591428028325601350
   PubMed Web of Science ®Google Scholar
• HubacherDReyesVLilloSZepedaAChenPLCroxattoHPain from copper intrauterine device insertion: randomized trial of prophylactic ibuprofenAm J Obstet Gynecol200619551272127717074548
   PubMed Web of Science ®Google Scholar
• LopezLMBernholcAZengYInterventions for pain with intrauterine device insertionCochrane Database Syst Rev20157CD00737326222246
   PubMed Web of Science ®Google Scholar
• FergusonCACostescuDJamiesonMAJongLTransmural migration and perforation of a levonorgestrel intrauterine system: a case report and review of the literatureContraception2016931818626386445
   PubMed Web of Science ®Google Scholar
• HeinemannKReedSMoehnerSMinhTDRisk of uterine perforation with levonorgestrel-releasing and copper intrauterine devices in the European Active Surveillance Study on Intrauterine DevicesContraception201591427427925601352
   PubMed Web of Science ®Google Scholar
• JatlaouiTCSimmonsKBCurtisKMThe safety of intrauterine contraception initiation among women with current asymptomatic cervical infections or at increased risk of sexually transmitted infectionsContraception Epub201661
   Web of Science ®Google Scholar
• SufrinCBPostlethwaiteDArmstrongMAMerchantMWendtJMSteinauerJENeisseria gonorrhea and Chlamydia trachomatis screening at intrauterine device insertion and pelvic inflammatory diseaseObstet Gynecol201212061314132123168755
   PubMed Web of Science ®Google Scholar
• MaddenTMcNicholasCZhaoQSecuraGMEisenbergDLPeipertJFAssociation of age and parity with intrauterine device expulsionObstet Gynecol2014124471872625198262
   PubMed Web of Science ®Google Scholar
• FaundesDPerdigaoAFaundesABahamondesLPettaCAT-shaped IUDs accommodate in their position during the first 3 months after insertionContraception200062416516811137069
   PubMed Web of Science ®Google Scholar
• RatsulaKToivonenJLahteenmakiPLuukkainenTPlasma levonorgestrel levels and ovarian function during the use of a levonorgestrel-releasing intracervical contraceptive deviceContraception19893921952042495893
   PubMed Web of Science ®Google Scholar
• PayneJBSundstromBDeMariaALA qualitative study of young women’s beliefs about intrauterine devices: fear of infertilityJ Midwifery Womens Health201661448248826971722
   PubMed Web of Science ®Google Scholar
• MaddenTMullersmanJLOmvigKJSecuraGMPeipertJFStructured contraceptive counseling provided by the Contraceptive CHOICE ProjectContraception201388224324922959396
   PubMed Web of Science ®Google Scholar
• DehlendorfCKrajewskiCBorreroSContraceptive counseling: best practices to ensure quality communication and enable effective contraceptive useClin Obstet Gynecol201457465967325264697
   PubMed Web of Science ®Google Scholar
• Committee on Adolescent Health Care Long-Acting Reversible Contraception Working Group, The American College of Obstetricians and GynecologistsCommittee opinion no. 539: adolescents and long-acting reversible contraception: implants and intrauterine devicesObstet Gynecol2012120498398822996129
   PubMedGoogle Scholar
• Society of Family PlanningUse of the Mirena IUS and Paragard CuT380A intrauterine devices in nulliparous womenContraception201081:5201036737120399942
   PubMed Web of Science ®Google Scholar
• American Academy of PediatricsContraception for adolescentsPediatrics20141344e1244e125625266430
   PubMed Web of Science ®Google Scholar
• SecuraGMMaddenTMcNicholasCProvision of no-cost, long-acting contraception and teenage pregnancyN Engl J Med20143711413161323
   Web of Science ®Google Scholar
• AbrahamMZhaoQPeipertJFYoung age, nulliparity, and continuation of long-acting reversible contraceptive methodsObstet Gynecol2015126482382926348177
   PubMed Web of Science ®Google Scholar
• Gemzell-DanielssonKBuhlingKJDermoutSMLukkari-LaxEMontegriffoEApterDA Phase III, single-arm study of LNG-IUS 8, a low-dose levonorgestrel intrauterine contraceptive system (total content 13.5 mg) in postmenarcheal adolescentsContraception201693650751226872720
   PubMed Web of Science ®Google Scholar
• Bayer Limited (Ireland)Mirena: summary of product characteristics Available from: http://www.medicines.ie/medicine/2707/SPC/Mirena+52mg+Intrauterine+Delivery+System/Accessed June 30, 2016
   Google Scholar
• RaudaskoskiTTapanainenJTomásEIntrauterine 10 microg and 20 microg levonorgestrel systems in postmenopausal women receiving oral oestrogen replacement therapy: clinical, endometrial and metabolic responseBJOG2002109213614411888095
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and PreventionU.S. selected practice recommendations for contraceptive use, 2013: adapted from the World Health Organization selected practice recommendations for contraceptive use, 2nd editionMMWR201362RR05146
   Google Scholar
• StulbergDBCainLRDahlquistILauderdaleDSEctopic pregnancy rates and racial disparities in the Medicaid population, 2004–2008Fertil Steril201410261671167625439806
   PubMed Web of Science ®Google Scholar